The Molecular Biology Revolution and the Rise of Bioscience Megacentres in North America and Europe

Philip Cooke
Additional contact information
Philip Cooke: Centre for Advanced Studies, and ESRC Centre for Social and Economic Analysis of Genomics (CESAGen) Cardiff University, Cardiff CF10 3BB, Wales

Environment and Planning C, 2004, vol. 22, issue 2, 161-177

Abstract: This paper focuses on ‘triple helix’ effects in biosciences. Scientific change can have profound socioeconomic effects. The molecular biology revolution tilted pharmaceuticals production away from its fine chemistry path dependence into microbiology and biotechnology. The key to any triple helix effects has thus shifted to universities and spinouts buttressed with burgeoning public funding, leaving ‘big pharma’ increasingly playing the role of licenser and marketer of bought-in therapeutic treatments. Concentration in the healthcare value chain means a few places that have become bioscience ‘mega-centres’ dominate healthcare innovation. Ambitious regions seeking to establish megacentres of their own are causing governments to experiment with ‘regional science policy’ to build up competitiveness.

Date: 2004
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (4)

Downloads: (external link)
https://journals.sagepub.com/doi/10.1068/c0344 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:sae:envirc:v:22:y:2004:i:2:p:161-177

DOI: 10.1068/c0344

Access Statistics for this article

More articles in Environment and Planning C
Bibliographic data for series maintained by SAGE Publications ().